Cargando…
Definitive hyperfractionated, accelerated proton reirradiation for patients with pelvic malignancies
INTRODUCTION: Pelvic reirradiation (re-RT) presents challenges due to concerns for late toxicity to tissues-at-risk including pelvic bone marrow (PBM). We routinely utilize a hyperfractionated, accelerated re-RT for recurrent rectal or anal cancer in the setting of prior radiation. We hypothesized t...
Autores principales: | Moningi, Shalini, Ludmir, Ethan B., Polamraju, Praveen, Williamson, Tyler, Melkun, Marcella M., Herman, Joseph D., Krishnan, Sunil, Koay, Eugene J., Koong, Albert C., Minsky, Bruce D., Smith, Grace L., Taniguchi, Cullen, Das, Prajnan, Holliday, Emma B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734102/ https://www.ncbi.nlm.nih.gov/pubmed/31517071 http://dx.doi.org/10.1016/j.ctro.2019.08.004 |
Ejemplares similares
-
Hyperfractionated abdominal reirradiation for gastrointestinal malignancies
por: Hunt, Andrew, et al.
Publicado: (2018) -
Treatment of primary rectal adenocarcinoma after prior pelvic radiation: The role of hyperfractionated accelerated reirradiation
por: Jensen, Garrett, et al.
Publicado: (2018) -
Contemporary use and outcomes of radiation and chemotherapy for unresectable pancreatic cancer
por: Moningi, Shalini, et al.
Publicado: (2022) -
Patient-Reported Outcomes After Chemoradiation in Patients With Anal Cancer: A Qualitative Analysis
por: Corrigan, Kelsey L., et al.
Publicado: (2022) -
Hyperfractionated-Accelerated Reirradiation with Proton Therapy for Radiation-Associated Breast Angiosarcoma
por: Looi, Wen Shen, et al.
Publicado: (2022)